Gyre Therapeutics (GYRE) Payables (2010 - 2026)
Gyre Therapeutics (GYRE) reported Payables of $1.24 million for Q2 2026, compared with $71,000 a year earlier and up 366.4% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics posted Payables of $1.34 million.
- Payables has a five-year compound annual growth rate of -25.8% (FY2020 to FY2025).
- By year, Payables came in at $108,000 in FY2024 (-69.6%), $355,000 in FY2023 (-95.4%), $7.68 million in FY2022 (+19.6%) and $6.42 million in FY2021 (+8.2%).
- Five-year quarterly Payables spans a low of $5,000 in Q2 2023 and a high of $7.68 million in Q4 2022.
- Year over year, Payables gained in three of the last six quarters, with growth averaging 14.3%.
- The high point for year-over-year Payables in five years was Q3 2023 (growth of 285.4%); the low point was Q1 2023 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $265,000 (Q1 2026), $1.34 million (Q4 2025) and $556,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 1.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 265,000.00 |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 556,000.00 |
| Jun 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 303,000.00 |
| Jun 30, 2024 | 271,000.00 |
| Mar 31, 2024 | 330,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | 7.68 Mn |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | 1.04 Mn |
| Mar 31, 2022 | 4.71 Mn |
| Dec 31, 2021 | 6.42 Mn |
| Sep 30, 2021 | 3.86 Mn |
API Access
Gyre Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();